+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Teriparatide"

Osteoporosis Drugs Global Market Report 2024 - Product Thumbnail Image

Osteoporosis Drugs Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Osteoporosis Treatment Global Market Report 2024 - Product Thumbnail Image

Osteoporosis Treatment Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Parathyroid Hormone Global Market Report 2024 - Product Thumbnail Image

Parathyroid Hormone Global Market Report 2024

  • Report
  • February 2024
  • 250 Pages
  • Global
From
Biosimilar Growth Hormones Global Market Report 2024 - Product Thumbnail Image

Biosimilar Growth Hormones Global Market Report 2024

  • Report
  • February 2024
  • 250 Pages
  • Global
From
Postmenopausal Osteoporosis Treatment Global Market Report 2024 - Product Thumbnail Image

Postmenopausal Osteoporosis Treatment Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Postmenopausal osteoporosis - Pipeline Insight, 2024 - Product Thumbnail Image

Postmenopausal osteoporosis - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 120 Pages
  • Global
From
Teriparatide- Biosimilar Insight, 2022 - Product Thumbnail Image

Teriparatide- Biosimilar Insight, 2022

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Disease Analysis: Osteoporosis - Product Thumbnail Image

Disease Analysis: Osteoporosis

  • Report
  • March 2021
  • 48 Pages
  • Global
Osteoporosis Market and Forecast Analysis - Product Thumbnail Image

Osteoporosis Market and Forecast Analysis

  • Report
  • January 2019
  • 212 Pages
  • Global
From
Drug Overview: Forteo - Product Thumbnail Image

Drug Overview: Forteo

  • Report
  • March 2018
  • 18 Pages
  • Global
From
From
Hypoparathyroidism - Pipeline Review, H2 2020 - Product Thumbnail Image

Hypoparathyroidism - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 75 Pages
  • Global
From
Bone Fracture - Pipeline Review, H2 2019 - Product Thumbnail Image

Bone Fracture - Pipeline Review, H2 2019

  • Drug Pipelines
  • November 2019
  • 75 Pages
  • Global
From
From
From
  • 20 Results (Page 1 of 1)
Loading Indicator

Teriparatide is a synthetic form of parathyroid hormone used to treat endocrine and metabolic disorders. It is used to treat osteoporosis in postmenopausal women and men at high risk of fracture, as well as to treat osteoporosis in men and women with glucocorticoid-induced osteoporosis. It is also used to treat Paget's disease of bone in adults. Teriparatide is administered as a subcutaneous injection and is available in both brand-name and generic forms. Teriparatide is a relatively new drug in the endocrine and metabolic disorders market, but it has been gaining traction in recent years. It is a safe and effective treatment for osteoporosis and other bone-related disorders, and its use is expected to continue to grow. Some companies in the Teriparatide market include Eli Lilly, Amgen, and Teva Pharmaceuticals. Show Less Read more